Publicaciones en colaboración con investigadores/as de University of Michigan–Ann Arbor (21)

2024

  1. A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results

    Haemophilia

  2. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  3. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  5. KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis

    Cancer Research Communications, Vol. 4, Núm. 7, pp. 1677-1689

2023

  1. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393

2022

  1. Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

    European Journal of Cancer, Vol. 174, pp. S116

  2. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts

    JAMA Oncology, Vol. 8, Núm. 3

  3. Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts

    BLOOD CANCER DISCOVERY, Vol. 3, Núm. 6

2021

  1. Comparison of Multimodal Therapies and Outcomes among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features

    JAMA Network Open, Vol. 4, Núm. 7

  2. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

    JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550

2017

  1. BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells

    Cancer Discovery, Vol. 7, Núm. 5, pp. 506-521

  2. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

    Open Heart, Vol. 4, Núm. 2

2016

  1. NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

    Cell, Vol. 166, Núm. 4, pp. 963-976

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling

    Journal of Biological Chemistry, Vol. 289, Núm. 40, pp. 27727-27743

2013

  1. MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC

    Leukemia, Vol. 27, Núm. 3, pp. 686-694

2008

  1. Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity

    Cancer Research, Vol. 68, Núm. 18, pp. 7684-7691

2002

  1. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons

    Journal of Neuroscience, Vol. 22, Núm. 21, pp. 9378-9386

  2. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication

    Human Gene Therapy, Vol. 13, Núm. 14, pp. 1737-1750